Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Lymphoma

Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL

Bone Marrow Transplantation volume 51, pages 807–812 (2016)Cite this article

Subjects

Abstract

High-dose chemotherapy and autologous stem cell transplantation (ASCT) for extranodal natural killer/T-cell lymphoma (ENKTL) is a reasonable option for a subset of patients. The impact of response status, according to positron emission tomography/computed tomography (PET/CT) results and/or presence of circulating EBV DNA prior to ASCT, has not yet been established. We analyzed 27 ENKTL patients with pre-ASCT circulating EBV DNA who had undergone pre-ASCT PET/CT between 2009 and 2014. We classified patients into two groups based on the result of pretransplantation assessment: a favorable risk group (pretransplant five-point Deauville score (DS) of 1–2 based on PET/CT and no detectable EBV DNA) and an unfavorable risk group (DS 1–2 with detectable EBV DNA, DS 3–5 with or without detectable EBV DNA). After a median follow-up of 37 months, overall survival and PFS were significantly different between the two groups (median OS: not reached for favorable risk group vs 7.0 months for unfavorable risk group, P=0.017; median PFS: 16.0 vs 5.0 months, P=0.019). Multivariate analysis revealed that pre-ASCT DS and EBV DNA was the only independent prognostic factor considering stage, IPI and NKPI. Precise assessment of the status of disease before transplantation may provide more benefit from ASCT to ENKTL patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Vose J, Armitage J, Weisenburger D . International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124–4130.

    Article  Google Scholar 

  2. Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol 2009; 27: 6027–6032.

    Article  CAS  Google Scholar 

  3. Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 2009; 27: 5594–5600.

    Article  CAS  Google Scholar 

  4. Yong W, Zheng W, Zhu J, Zhang Y, Wang X, Xie Y et al. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Ann Hematol 2009; 88: 647–652.

    Article  CAS  Google Scholar 

  5. Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011; 29: 4410–4416.

    Article  CAS  Google Scholar 

  6. Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T, Tse E et al. SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 2012; 120: 2973–2980.

    Article  CAS  Google Scholar 

  7. Lee J, Au WY, Park MJ, Suzumiya J, Nakamura S, Kameoka J et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008; 14: 1356–1364.

    Article  Google Scholar 

  8. Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka JI, Sakai C et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006; 37: 425–431.

    Article  CAS  Google Scholar 

  9. Kim HJ, Bang SM, Lee J, Kwon HC, Suh C, Kim HJ et al. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant 2006; 37: 819–824.

    Article  CAS  Google Scholar 

  10. Bang SM, Kim YK, Park YH, Sohn SK, Lee JJ, Cho EK et al. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma. Leuk Lymphoma 2005; 46: 1599–1604.

    Article  CAS  Google Scholar 

  11. Au WY, Lie AK, Liang R, Kwong YL, Yau CC, Cheung MM et al. Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value. Ann Oncol 2003; 14: 1673–1676.

    Article  CAS  Google Scholar 

  12. Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC et al. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Lancet Haematol 2015; 2: e66–e74.

    Article  Google Scholar 

  13. Meignan M, Gallamini A, Itti E, Barrington S, Haioun C, Polliack A . Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus. Leuk Lymphoma 2012; 53: 1876–1881.

    Article  Google Scholar 

  14. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014; 32: 3048–3058.

    Article  Google Scholar 

  15. Kim HS, Kim KH, Kim KH, Chang MH, Ji SH, Lim do H et al. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma. Leuk Lymphoma 2009; 50: 757–763.

    Article  CAS  Google Scholar 

  16. Germi R, Lupo J, Semenova T, Larrat S, Magnat N, Grossi L et al. Comparison of commercial extraction systems and PCR assays for quantification of Epstein-Barr virus DNA load in whole blood. J Clin Microbiol 2012; 50: 1384–1389.

    Article  Google Scholar 

  17. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612–618.

    Article  Google Scholar 

  18. Liang R, Chen F, Lee CK, Kwong YL, Chim CS, Yau CC et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 1997; 19: 91–93.

    Article  CAS  Google Scholar 

  19. Fox CP, Boumendil A, Schmitz N, Finel H, Luan JJ, Sucak G et al. High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation. Leuk Lymphoma 2015; 56: 3295–3300.

    Article  CAS  Google Scholar 

  20. Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y et al. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma. Biol Blood Marrow Transplant 2015; 21: 1597–1604.

    Article  CAS  Google Scholar 

  21. Kim CY, Hong CM, Kim DH, Son SH, Jeong SY, Lee SW et al. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on (1)(8)F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma. Eur J Nucl Med Mol Imaging 2013; 40: 1321–1329.

    Article  CAS  Google Scholar 

  22. Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M et al. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med 2013; 54: 683–690.

    Article  CAS  Google Scholar 

  23. Sauter CS, Matasar MJ, Meikle J, Schoder H, Ulaner GA, Migliacci JC et al. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood 2015; 125: 2579–2581.

    Article  CAS  Google Scholar 

  24. Alcantara M, Dupuis J, Mareschal S, Julian A, Cottereau AS, Becker S et al. PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma. Eur J Nucl Med Mol Imaging 2015; 42: 215–221.

    Article  CAS  Google Scholar 

  25. Khong PL, Huang B, Phin Lee EY, Sum Chan WK, Kwong YL . Midtreatment 18 F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center. J Nucl Med 2014; 55: 911–916.

    Article  CAS  Google Scholar 

  26. Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K et al. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type. Clin Cancer Res 2012; 18: 4183–4190.

    Article  CAS  Google Scholar 

  27. Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y et al. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type. Blood 2011; 118: 6018–6022.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    S H Lim, H S Kim, J Y Lee, K H Yoo, K S Jung, H-N Song, J Cho, S Park, S J Kim & W S Kim

  2. Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    S H Hyun & J Y Choi

  3. Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    Y H Ko

Authors
  1. S H Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S H Hyun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H S Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Y Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K H Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K S Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H-N Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Y H Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J Y Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. W S Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to J Y Choi or W S Kim.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, S., Hyun, S., Kim, H. et al. Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL. Bone Marrow Transplant 51, 807–812 (2016). https://doi.org/10.1038/bmt.2016.6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2016.6

This article is cited by

Search

Advanced search

Quick links